Navigation Links
ImQuest Scientists Present Important HIV Microbicide Development Results at Microbicides 2008 in Delhi, India
Date:4/8/2008

smission of HIV.

ImQuest Life Sciences, a privately held U.S. company located in Frederick, Maryland specializes in the preclinical and clinical development of novel compounds for the treatment of infectious disease and cancer. ImQuest BioSciences, also located in Frederick, Maryland, is a leading provider of anti-infective and anti-cancer drug and vaccine development services to the biotechnology and pharmaceutical industry. Both companies are highly involved in efforts to develop an effective anti-HIV topical microbicide.

For further information regarding this press release please contact:

Robert W. Buckheit, Jr., Ph.D.

Executive Vice President and Chief Scientific Officer

ImQuest Life Sciences, Inc.

301-696-0274

rbuckheit@imquest.com


'/>"/>
SOURCE ImQuest Life Sciences
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. ImQuest Publishes Results of Important Structure Activity Relationship Program on Dual Acting Pyrimidinediones
2. Neuroscientists Offer Hope for Breast Cancer Patients Suffering From Chemobrain
3. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
4. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
5. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
8. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
9. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
10. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
11. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Naurex Inc., a new clinical stage ... CNS disorders based on its novel GFPA NMDA ... a major medical meeting showed that its lead ... with no signs of the CNS-related side effects ... The studies also showed that GLYX-13,s antidepressant ...
(Date:12/16/2009)... -- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR ) ... J.P. Morgan Healthcare Conference at the Westin St. ... 13, 2010. Michael N. Chang, Optimer,s President and ... Pacific Time (5:30 p.m. Eastern Time). ,, (Logo: ... of this presentation will be accessible on the ...
(Date:12/16/2009)... Advanced Life Sciences Holdings, Inc. (OTC ... from a pivotal, non-human primate study of its ... inhaled lethal dose of tularemia. A 14-day course ... the doses tested. All of the ten ... once-a-day of Restanza (approximate to a human dose ...
Breaking Medicine Technology:Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 2Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 3Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 4Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 5Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 6Optimer Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference 2Advanced Life Sciences' Restanza Shows 100% Survival in Tularemia Pivotal Animal Study 2Advanced Life Sciences' Restanza Shows 100% Survival in Tularemia Pivotal Animal Study 3Advanced Life Sciences' Restanza Shows 100% Survival in Tularemia Pivotal Animal Study 4Discovery may provide new treatments for alcohol dependence 9070 1Discovery may provide new treatments for alcohol dependence 9070 2Cadient Group Wins Nine Communicator Awards 50411 1Cadient Group Wins Nine Communicator Awards 50411 2Cadient Group Wins Nine Communicator Awards 50411 3Renal Physicians Association Participates in PEAK Campaign 50406 1
... published by the,Clinical Resource Efficiency Support Team (CREST) ... for the early assessment of,lymphedema., The published ... Assessment and Management of Lymphoedema" are the result ... that,reviewed the evidence for diagnosing, assessing and treating ...
... Phase 2a Trial, WALTHAM, Mass., June 12 ... that based on feedback from the Food and,Drug ... 2b clinical,trial of RG2417, an oral formulation of ... This will be a multi-center, parallel arm,placebo-controlled, clinical ...
Other Medicine Technology:Published Guidelines Further Support Use of Bioimpedance Measurement Technology for Early Assessment of Lymphedema 2Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder 2Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder 3Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder 4Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder 5
(Date:12/16/2009)... the development of products that help survivors of stroke and ... the publication of an interview with the inventors of their ... Physical Therapy and Rehab Medicine, vol. 20, issue 20, page ... ... (PRWEB) December 16, 2009 -- In the ...
(Date:12/16/2009)... Hair Shake in all of the Florida Whole Foods store. ... ... Larry Shapiro, hair transplant and hair loss physician , is pleased ... Hair Whey Protein Shake. Dr. Shapiro developed the all natural growth-hormone ... programs, working out and muscle building., , , , ,The Whole Foods ...
(Date:12/15/2009)... SUMMARY: The U.S. Senate ... and Affordable Care Act that would have helped ... the safe and legal importation of lower priced ... AARP and sponsored by Senators Dorgan, Snowe, McCain, ... helped to bring down the skyrocketing costs of ...
(Date:12/15/2009)... Palo Alto Networks(TM), the network security ... its PA-4000 Series next-generation firewalls for accurate threat ... visibility and control over applications such as peer-to-peer ... national university with eight facilities on five campuses. ... a number of academic schools and institutions throughout ...
(Date:12/15/2009)... Vitech Systems Group, a leading provider of Benefits ... today that it has completed a major V3 ... Guild-Producers Pension & Health Plans (SAG-PH). ,, The ... SAG-PH call center personnel in Burbank, Ventura and ... V3 Benefits Administration System which consolidated data from ...
Breaking Medicine News(10 mins):Health News:New Tailwind Device Improves Arm Function in Stroke Survivors with Paralysis 2Health News:Florida Whole Foods Stores to Carry Dr. Lawrence Shapiro's Help Hair Shake 2Health News:AARP Disappointed By Senate Vote Against Lower Prescription Drug Prices 2Health News:AARP Disappointed By Senate Vote Against Lower Prescription Drug Prices 3Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 2Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 3Health News:Screen Actors Guild - Producers Pension & Health Plans Live on New CRM Solution 2
... October 15 Sanofi Pasteur, the,vaccines division ... Institut Pasteur to develop a vaccine against ... have access to antigens,identified by Institut Pasteur ... the most deadly malaria infections. Sanofi Pasteur,intends ...
... Time, 11:30 am EDT, TEL AVIV, Israel, October ... yesterday that it has signed,an agreement to acquire 100% ... and Blessing Biotech GmbH (together the "Gewurzmuller,Group"), in consideration ... 47.3,million). The Company will be hosting a conference ...
... GOLDEN, Colo. (October 15, 2007) Patients have on ... the nations top-rated hospitals compared with the lowest-rated hospitals ... annual HealthGrades Hospital Quality in America Study, issued today ... documents a wide variation in the quality of care ...
... cancer organizations shows cancer death rates decreased on average ... twice the annual decrease of 1.1 percent per year ... the Annual Report to the Nation on the Status ... Alaska Natives published online October 15, 2007 ( www.interscience.wiley.com/cancer/report2007 ...
... one likely contributor to the way that some folks eat ... the University at Buffalo, The State University of New York, ... that helps make behaviors and substances more rewarding, find food ... short, they are more motivated to eat and they eat ...
... Princeton-led research team has created an easy-to-produce material ... the rare ability to bend light in the ... startling property may contribute to significant advances in ... detection of terrorist threats. A Princeton-led research team ...
Other Medicine News:Health News:Sanofi Pasteur and Institut Pasteur Team up Against Malaria 2Health News:Sanofi Pasteur and Institut Pasteur Team up Against Malaria 3Health News:Frutarom Gewurzmuller and Blessing Biotech Acquisition Conference Call Scheduled for Monday, October 15, 2007 2Health News:Mortality rates 71 percent lower at top-rated hospitals: HealthGrades 2008 hospital-quality study 2Health News:Mortality rates 71 percent lower at top-rated hospitals: HealthGrades 2008 hospital-quality study 3Health News:Annual report to the nation finds cancer death rate decline doubling 2Health News:Annual report to the nation finds cancer death rate decline doubling 3Health News:Annual report to the nation finds cancer death rate decline doubling 4Health News:Genes may make some people more motivated to eat, perhaps overeat 2Health News:Genes may make some people more motivated to eat, perhaps overeat 3Health News:Novel semiconductor structure bends light 'wrong' way -- the right direction for many applications 2Health News:Novel semiconductor structure bends light 'wrong' way -- the right direction for many applications 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: